Hunan ER-KANG Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hunan ER-KANG Pharmaceutical Co Ltd with three other
companies in this sector in China:
Hainan Haiyao Company Limited
sales of 1.67 billion Chinese Renmimbi [US$248.57 million]
of which 59%
PKU HealthCare Corp Ltd
(2.01 billion Chinese Renmimbi [US$298.39 million]
of which 63%
was Merchandise&Material Selling), and
Yabao Pharmaceutical Group Company Limited
(2.07 billion Chinese Renmimbi [US$306.48 million]
of which 80%
was Pharrmaceutical Manufacturing).
Hunan ER-KANG Pharmaceutical Co Ltd reported sales of 1.76 billion Chinese Renmimbi (US$260.59 million)
December of 2015.
increase of 28.1%
versus 2014, when the company's sales were 1.37 billion Chinese Renmimbi.
Sales at Hunan ER-KANG Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2010, sales have increased a total of 382%).